Management of hypertrophic cardiomyopathy

被引：2

作者：

Zhang, Yuhui ^{[1
]}

Adamo, Marianna ^{[2
,3
]}

Zou, Changhong ^{[1
]}

Porcari, Aldostefano ^{[4
]}

Tomasoni, Daniela ^{[2
,3
]}

Rossi, Maddalena ^{[4
]}

Merlo, Marco ^{[4
]}

Liu, Huihui ^{[1
]}

Wang, Jinxi ^{[1
]}

Zhou, Ping ^{[1
]}

Metra, Marco ^{[2
,3
,6
]}

Sinagra, Gianfranco ^{[4
]}

Zhang, Jian ^{[1
,5
]}

机构：

[1] Chinese Acad Med Sci, Heart Failure Care Unit, Heart Failure Ctr, Fuwai Hosp,Peking Union Med Coll,Natl Ctr Cardiova, Beijing 100045, Peoples R China

[2] Univ Brescia, Cardiol, ASST Spedali Civili, Brescia, Italy

[3] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

[4] Azienda Sanitaria Univ Integrata Trieste, Div Cardiol, Cardiovasc Dept, Trieste, Italy

[5] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Beijing 100037, Peoples R China

[6] Univ Brescia, Brescia, Italy

来源：

JOURNAL OF CARDIOVASCULAR MEDICINE | 2024年 / 25卷 / 06期

关键词：

hypertrophic cardiomyopathy; management; update; ALCOHOL SEPTAL ABLATION; SUDDEN-DEATH RISK; ASSOCIATION JOINT COMMITTEE; OUTFLOW TRACT OBSTRUCTION; ATRIAL-FIBRILLATION; AMERICAN-COLLEGE; SYMPTOMATIC PATIENTS; EUROPEAN-SOCIETY; CLINICAL PROFILE; HEART-FAILURE;

D O I：

10.2459/JCM.0000000000001616

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy is an important cause of heart failure and arrhythmias, including sudden death, with a major impact on the healthcare system. Genetic causes and different phenotypes are now increasingly being identified for this condition. In addition, specific medications, such as myosin inhibitors, have been recently shown as potentially able to modify its symptoms, hemodynamic abnormalities and clinical course. Our article aims to provide a comprehensive outline of the epidemiology, diagnosis and treatment of hypertrophic cardiomyopathy in the current era.

引用

页码：399 / 419

页数：21

共 50 条

[1] MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY
HESS, OM
KRAYENBUEHL, HP
[J]. CURRENT OPINION IN CARDIOLOGY, 1993, 8 (03) : 434 - 440
[2] Management of hypertrophic cardiomyopathy
Elliott, PM
McKenna, WJ
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 55 (07): : 419 - 423
[3] Management of Hypertrophic Cardiomyopathy
Enriquez, Alan D.
Goldman, Martin E.
[J]. ANNALS OF GLOBAL HEALTH, 2014, 80 (01): : 35 - 45
[4] MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY
HOPF, R
KALTENBACH, M
[J]. ANNUAL REVIEW OF MEDICINE, 1990, 41 : 75 - 83
[5] Management of hypertrophic cardiomyopathy
Spirito, Paolo
Autore, Camillo
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7552): : 1251 - 1255
[6] Diagnosis and management of hypertrophic cardiomyopathy
Pantazis A.
Vischer A.S.
Perez-Tome M.C.
Castelletti S.
[J]. Echo Research & Practice, 2015, 2 (1): : R45 - R53
[7] The management of hypertrophic cardiomyopathy - Reply
Maron, BJ
Spirito, P
McKenna, WJ
Seidman, CE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05): : 349 - 350
[8] MANAGEMENT OF ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
STEWART, JT
MCKENNA, WJ
[J]. CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (01) : 95 - 99
[9] Current management of hypertrophic cardiomyopathy
Coats C.J.
Elliott P.M.
[J]. Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 496 - 504
[10] Current management of hypertrophic cardiomyopathy
Golledge, P
Knight, CJ
[J]. HOSPITAL MEDICINE, 2001, 62 (02): : 79 - 82

← 1 2 3 4 5 →